Bath & Body Works (NYSE:BBWI) Earns Hold Rating from Argus

Argus reiterated their hold rating on shares of Bath & Body Works (NYSE:BBWI - Free Report) in a research note published on Friday morning,Benzinga reports.

A number of other research firms also recently issued reports on BBWI. Wells Fargo & Company raised shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and upped their price target for the company from $42.00 to $48.00 in a research note on Friday. Deutsche Bank Aktiengesellschaft upped their target price on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a "buy" rating in a research report on Tuesday, November 26th. Telsey Advisory Group reiterated an "outperform" rating and issued a $42.00 price target on shares of Bath & Body Works in a research report on Monday, November 25th. Piper Sandler upped their price objective on Bath & Body Works from $36.00 to $39.00 and gave the company a "neutral" rating in a research report on Monday. Finally, Barclays lifted their target price on Bath & Body Works from $28.00 to $34.00 and gave the stock an "underweight" rating in a report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $43.06.

Bath & Body Works Stock Performance

Shares of BBWI traded down $0.52 during mid-day trading on Friday, reaching $36.45. The stock had a trading volume of 3,796,599 shares, compared to its average volume of 3,314,983. The business has a fifty day moving average of $35.75 and a 200 day moving average of $33.77. The firm has a market cap of $7.89 billion, a price-to-earnings ratio of 8.89, a PEG ratio of 1.43 and a beta of 1.82. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same quarter in the prior year, the company posted $0.48 earnings per share. The business's quarterly revenue was up 3.1% compared to the same quarter last year. On average, research analysts forecast that Bath & Body Works will post 3.26 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 22nd were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.19%. Bath & Body Works's dividend payout ratio is presently 19.51%.

Hedge Funds Weigh In On Bath & Body Works

A number of large investors have recently bought and sold shares of BBWI. True Wealth Design LLC raised its position in shares of Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock worth $34,000 after purchasing an additional 1,054 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in shares of Bath & Body Works by 300.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company's stock valued at $38,000 after acquiring an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new position in shares of Bath & Body Works in the third quarter valued at approximately $39,000. TD Private Client Wealth LLC boosted its stake in shares of Bath & Body Works by 24.2% in the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock worth $54,000 after acquiring an additional 331 shares during the last quarter. Finally, Meeder Asset Management Inc. increased its position in shares of Bath & Body Works by 480.3% during the third quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company's stock worth $55,000 after purchasing an additional 1,436 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.